Pulmano, Rizel Mae .
HRN: 21-45-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2022
CEFUROXIME 500MG (TAB)
06/07/2022
06/13/2022
PO
500mg
BID
Post CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes